680 Multi-parametric assessment of the immune response to a trio immunotherapy in patients with recurrent or metastatic head and neck squamous cell carcinoma
Christopher Paustian(UbiVac (United States)), Rom S. Leidner(Providence Portland Medical Center), Noriko Iwamoto(Shimadzu (Japan)), Marcus Couey(Providence Portland Medical Center), Tarsem Moudgil(Providence Portland Medical Center), Walter J. Urba(Providence Portland Medical Center), Yuriko Minegishi(National Institutes of Health), Koji Ueda(RIKEN Center for Integrative Medical Sciences), Matthew H. Taylor(Providence Portland Medical Center), Lessli Rushforth(Providence Portland Medical Center), R. Bryan Bell(Takara (United States)), Shawn M. Jensen(Providence Portland Medical Center), Tanisha Christie(Providence Portland Medical Center), Venkatesh Rajamanickam(Cancer Institute (WIA)), Carlo Bifulco(Providence Health & Services), Quyen Vu(Providence Portland Medical Center), Noah D. Simons(Providence Portland Medical Center), Bernard A. Fox(Oregon Health & Science University), Tyler Hulett(CDI Laboratories (United States)), Brady Bernard(Providence Portland Medical Center), Traci Hilton(UbiVac (United States)), Yoshinobu Koguchi(Providence Portland Medical Center), Brian Piening(Providence College), Takashi Shimada(Keio University), Ryan Meng(Providence Portland Medical Center), Hong‐Ming Hu(Viva Biotech (China)), Abigail L. Peterson(Providence Portland Medical Center), William L. Redmond(Providence St. Vincent Medical Center)
Cited by 0
Related Papers
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.6k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
|Cell|2018|4k
Genomic Classification of Cutaneous Melanoma
|Cell|2015|3.3k